JP2024532261A5 - - Google Patents

Info

Publication number
JP2024532261A5
JP2024532261A5 JP2024512004A JP2024512004A JP2024532261A5 JP 2024532261 A5 JP2024532261 A5 JP 2024532261A5 JP 2024512004 A JP2024512004 A JP 2024512004A JP 2024512004 A JP2024512004 A JP 2024512004A JP 2024532261 A5 JP2024532261 A5 JP 2024532261A5
Authority
JP
Japan
Prior art keywords
seq
nucleic acid
acid molecule
molecule according
nucleotides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024512004A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024532261A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/075187 external-priority patent/WO2023028441A1/en
Publication of JP2024532261A publication Critical patent/JP2024532261A/ja
Publication of JP2024532261A5 publication Critical patent/JP2024532261A5/ja
Pending legal-status Critical Current

Links

JP2024512004A 2021-08-23 2022-08-19 操作itr配列および使用方法 Pending JP2024532261A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
USPCT/US2021/047207 2021-08-23
USPCT/US2021/047207 2021-08-23
US202263310042P 2022-02-14 2022-02-14
US63/310,042 2022-02-14
PCT/US2022/075187 WO2023028441A1 (en) 2021-08-23 2022-08-19 Engineered itr sequences and methods of use

Publications (2)

Publication Number Publication Date
JP2024532261A JP2024532261A (ja) 2024-09-05
JP2024532261A5 true JP2024532261A5 (cg-RX-API-DMAC7.html) 2025-08-26

Family

ID=91165652

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024512004A Pending JP2024532261A (ja) 2021-08-23 2022-08-19 操作itr配列および使用方法

Country Status (5)

Country Link
US (1) US20240350671A1 (cg-RX-API-DMAC7.html)
EP (1) EP4392444A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024532261A (cg-RX-API-DMAC7.html)
CN (1) CN118103393A (cg-RX-API-DMAC7.html)
WO (1) WO2023028441A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2020001593A (es) 2017-08-09 2020-07-13 Bioverativ Therapeutics Inc Moleculas de acido nucleico y usos de las mismas.
JP7602454B2 (ja) 2018-08-09 2024-12-18 バイオベラティブ セラピューティクス インコーポレイテッド 核酸分子及び非ウイルス遺伝子治療のためのそれらの使用
JP2025525583A (ja) 2022-07-19 2025-08-05 ランパート バイオサイエンス インコーポレイテッド 非免疫原性環状非ウイルス性dnaベクター
CN120981563A (zh) * 2023-03-24 2025-11-18 南京金斯瑞生物科技有限公司 一种提升质粒稳定性的宿主细胞

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2014251099B2 (en) * 2013-04-08 2019-01-17 The University Of Kansas Chimeric adeno-associated virus/ bocavirus parvovirus vector
KR20180118659A (ko) 2016-02-01 2018-10-31 바이오버라티브 테라퓨틱스 인크. 최적화된 viii 인자 유전자
US11142775B2 (en) * 2017-01-13 2021-10-12 University Of Iowa Research Foundation Bocaparvovirus small noncoding RNA and uses thereof
MX2020001593A (es) * 2017-08-09 2020-07-13 Bioverativ Therapeutics Inc Moleculas de acido nucleico y usos de las mismas.
JP7602454B2 (ja) 2018-08-09 2024-12-18 バイオベラティブ セラピューティクス インコーポレイテッド 核酸分子及び非ウイルス遺伝子治療のためのそれらの使用

Similar Documents

Publication Publication Date Title
CN111492056B (zh) 用于细胞的遗传修饰的非整合型dna载体
JP2025113389A (ja) 無細胞合成から得ることができる閉端DNAベクターおよびceDNAベクターを得るためのプロセス
JP2022517174A5 (cg-RX-API-DMAC7.html)
JP7795357B2 (ja) Fviii治療薬を発現するための非ウイルス性dnaベクターおよびその使用
US10047365B2 (en) Replicative minicircle vectors with improved expression
JP7583732B2 (ja) フェニルアラニンヒドロキシラーゼ(pah)治療薬を発現するための非ウイルス性dnaベクターおよびその使用
EP2169072A1 (en) Multiple RNA polymerase III promoter expression constructs
JP2024534124A5 (cg-RX-API-DMAC7.html)
JP2022520803A (ja) 閉端DNA(ceDNA)の産生におけるREPタンパク質活性の調節
US20220184231A1 (en) Closed-ended dna (cedna) and immune modulating compounds
US7094399B2 (en) Use of spliceosome mediated RNA trans-splicing to confer cell selective replication to adenoviruses
IL296660A (en) Non-viral DNA vectors and their use for therapeutic expression of factor ix
CA3186894A1 (en) Tandem anellovirus constructs
US20100203627A1 (en) Long-term in vivo transgene expression
JP2024501287A (ja) RNAを閉じ込めたアネロウイルス(Anellovirus)キャプシドのインビトロアセンブリ
US20240026374A1 (en) Closed-ended dna vectors and uses thereof for expressing phenylalanine hydroxylase (pah)
WO2024083095A1 (zh) 环状rna及载体和载体的应用
US20230383311A1 (en) Non-viral dna vectors and uses thereof for expressing fviii therapeutics
WO2022068884A1 (zh) 核酸递送方法及系统
TWI903434B (zh) 具有改良負載基因表現率及降低基因毒性之腺相關病毒之經修飾複合體平台
CN114391040A (zh) 用于调节载脂蛋白b(apob)基因表达的组合物和方法
IL325131A (en) RNAi targeting KIF1A missense mutations for the treatment of KIF1A-related neurological disorder
EP4008785A1 (en) Circular nucleic acids and uses thereof for interfering with genome expression and proliferation of coronaviruses
CN108517335A (zh) 一种肝细胞miR-199b低表达的慢病毒表达载体及其构建方法
WO2025065890A1 (zh) 一种重组腺相关病毒颗粒、重组腺相关病毒载体系统及其应用